Skip to main content
森萱医药 logo

森萱医药 — Investor Relations & Filings

Ticker · 920946 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 417 across all filing types
Latest filing 2025-05-11 Regulatory Filings
Country CN China
Listing Beijing Stock Exchange 920946

About 森萱医药

https://www.senxuan.cn/

Jiangsu Senxuan Pharmaceutical Co., Ltd. specializes in the research, development, and production of pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and specialized fine chemicals. The company’s product portfolio includes key intermediates for antiviral medications, such as those used in the treatment of HIV, and anticonvulsant agents like Primidone. Additionally, it produces high-purity chemical solvents including 1,4-dioxane and 1,3-dioxolane for diverse industrial applications. Senxuan Pharmaceutical maintains a focus on advanced chemical synthesis and large-scale manufacturing capabilities, adhering to international quality standards to support the global life sciences and chemical sectors. Its operations are characterized by a commitment to technical innovation and the supply of critical chemical building blocks for complex therapeutic formulations.

Recent filings

Filing Released Lang Actions
2024年年度股东会法律意见书
Regulatory Filings Classification · 67% confidence The document is a ‘法律意见书’ (legal opinion letter) issued by a law firm on the legality and validity of the 2024 Annual Shareholders’ Meeting, including detailed vote counts for each proposal. While it contains voting results, it primarily serves as a legal opinion attestation rather than a straightforward vote-results announcement or the meeting materials themselves. Under the certification rule (attestations and compliance documents are classified under Regulatory Filings), this falls into the RNS (Regulatory Filings) category rather than DVA or AGM materials.
2025-05-11 Chinese
投资者关系活动记录表
Investor Presentation Classification · 90% confidence The document is titled as an "投资者关系活动记录表" which translates to "Investor Relations Activity Record". It specifically mentions an "业绩说明会" which means "Performance Explanation Meeting" or "Earnings Explanation Meeting". The content includes Q&A about the company's 2024 annual report performance, market sales, project status, and future strategy. The document is short (1329 characters) and appears to be a record or summary of an investor relations event rather than the full financial report itself. This matches the description of an Investor Presentation (IP) rather than a full Annual Report (10-K) or Earnings Release (ER). It is not a transcript of a call but a record of a performance explanation meeting. Therefore, the best classification is Investor Presentation (IP).
2025-05-08 Chinese
2024年年度报告业绩说明会预告公告
AGM Information Classification · 95% confidence The document is a notice announcing a scheduled performance explanation meeting related to the 2024 Annual Report of Jiangsu Senxuan Pharmaceutical Co., Ltd. It references the 2024 Annual Report and its summary already disclosed but does not contain the report itself or detailed financial data. The document invites investors to participate in the meeting and submit questions. The length is short (1288 characters), and the content is clearly an announcement of a meeting to discuss the annual report, not the report itself. Therefore, it fits the category of AGM Information (AGM-R) as it relates to materials shared during an annual general meeting or similar investor meeting focused on the annual report performance explanation.
2025-04-28 Chinese
2025年一季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2025 年第一季度报告" which translates to "2025 First Quarter Report." It contains detailed financial statements including consolidated balance sheets, profit and loss statements, cash flow statements, and notes on financial data for the quarter ending March 31, 2025. The document explicitly states it is a quarterly report and includes comprehensive financial data and analysis for the period January to March 2025. It is unaudited but contains substantive financial information typical of an interim or quarterly report. There is no indication that this is an announcement or a certification document; it is the actual report itself. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q1 2025
2025-04-28 Chinese
第四届监事会第九次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of Jiangsu Senxuan Pharmaceutical Co., Ltd. regarding the approval of the company's 2025 first quarter report. It references the actual quarterly report published on the Beijing Stock Exchange information disclosure platform but does not contain the financial data or substantive analysis itself. The document is short (935 characters) and serves as an official meeting resolution announcement rather than the report itself. According to the 'Menu vs Meal' rule, this is an announcement related to a report, not the report itself. Therefore, the appropriate classification is Regulatory Filings (RNS), which is the fallback for such announcements that do not fit other categories.
2025-04-28 Chinese
第四届董事会第九次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the ninth meeting of the fourth board of directors of Jiangsu Senxuan Pharmaceutical Co., Ltd. It includes details about the meeting date, attendance, and voting results. The key agenda item was the approval of the company's 2025 first quarter report, which is referenced as being disclosed separately on the Beijing Stock Exchange information platform. The document does not contain the actual financial report or detailed financial data but rather announces the board's approval of that report. The document length is short (1077 characters) and serves as a meeting resolution announcement rather than the report itself. Therefore, it fits best under the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors.
2025-04-28 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.